IRadimed (IRMD) Research Hub

IRadimed (IRMD) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 82.22 USD (-1.60%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 50.58, market cap 1.21B. This hub links to the full technical, earnings and options research available for IRMD.

Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNASDAQ, US
Last close82.22 USD (-1.60%)
52-week range81.62 USD – 102.99 USD
Trend regimeRange
14-day RSI16.3 (Oversold)
Trailing P/E50.58
Market cap1.21B
Dividend yield1.32%
Next earnings2026-07-30

Available research for IRMD

Earnings

IRMD earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E 50.58. Updated 2026-07-23.

Options: Covered Call

Covered Call on IRMD: how it works, illustrative setup around the real 82.22 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on IRMD: how it works, illustrative setup around the real 82.22 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on IRMD: how it works, illustrative setup around the real 82.22 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

IRMD technical analysis: range, last 82.22 USD, RSI 16.3, 52w range 81.62 USD–102.99 USD, real support/resistance. Updated 2026-09-11.

Frequently asked questions

What sector is IRMD in?

IRadimed (IRMD) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.

Is IRMD in an uptrend or downtrend?

As of 2026-09-11, IRMD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is IRMD's trailing P/E ratio?

IRMD's trailing P/E is 50.58, with a market cap of 1.21B. See the earnings research page for full valuation detail.

When does IRMD next report earnings?

IRMD is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of 0.44 USD.